Skip to main content Accessibility help
×
Home

Nutrition economics – characterising the economic and health impact of nutrition

  • I. Lenoir-Wijnkoop (a1), M. Dapoigny (a2), D. Dubois (a3), E. van Ganse (a4), I. Gutiérrez-Ibarluzea (a5) (a6), J. Hutton (a7), P. Jones (a8), T. Mittendorf (a9), M. J. Poley (a10), S. Salminen (a11) and M. J. C. Nuijten (a10) (a12)...

Abstract

There is a new merging of health economics and nutrition disciplines to assess the impact of diet on health and disease prevention and to characterise the health and economic aspects of specific changes in nutritional behaviour and nutrition recommendations. A rationale exists for developing the field of nutrition economics which could offer a better understanding of both nutrition, in the context of having a significant influence on health outcomes, and economics, in order to estimate the absolute and relative monetary impact of health measures. For this purpose, an expert meeting assessed questions aimed at clarifying the scope and identifying the key issues that should be taken into consideration in developing nutrition economics as a discipline that could potentially address important questions. We propose a first multidisciplinary outline for understanding the principles and particular characteristics of this emerging field. We summarise here the concepts and the observations of workshop participants and propose a basic setting for nutrition economics and health outcomes research as a novel discipline to support nutrition, health economics and health policy development in an evidence and health-benefit-based manner.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Nutrition economics – characterising the economic and health impact of nutrition
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Nutrition economics – characterising the economic and health impact of nutrition
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Nutrition economics – characterising the economic and health impact of nutrition
      Available formats
      ×

Copyright

The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence . The written permission of Cambridge University Press must be obtained for commercial re-use.

Corresponding author

*Corresponding author: I. Lenoir-Wijnkoop, email irene.lenoir@danone.com

References

Hide All
1WHO/FAO Expert Consultation (2003) Diet, Nutrition and the Prevention of Chronic Diseases. Report of a Joint WHO/FAO Expert Consultation, pp. 1149. WHO Technical Report Series no. 916. Geneva: WHO.
2Watson, R (2006) Health spending rising faster than GDP in most rich countries. BMJ 333, 60. http://www.bmj.com/cgi/content/full/333/7558/60-a/DC1.
3Health Enhancing Foods (2006) Agriculture and Rural Development Discussion Paper 30. The Worldbank. http://siteresources.worldbank.org/INTARD/Resources/Health_Enhacing_Foods_ARD_DP_30_final.pdf.
4Functional Food in the European Union (2008) European Commission, Joint Research Centre, Institute for Prospective Technological Studies. http://ftp.jrc.es/EURdoc/JRC43851.pdf.
5Richtlijnen voor farmaco-economisch onderzoek, College voor zorgverzekeringen, Diemen (2006) Updated version. http://www.cvz.nl.
6Cleemput, I, Van Wilder, P, Vrijens, F, et al. (2008) Guidelines for pharmacoeconomic evaluations in Belgium. Federal Health Care Knowledge Centre KCE Reports 78C.
7NICE (2008) Guide to the Methods of Technology Appraisal. http//www.nice.org.uk.
8Tan-Torres Edejer, T, Baltussen, R, Adam, T, et al. (2003) Making choices in health. WHO Guide to Cost-Effectiveness Analysis. Geneva: World Health Organization.
9Graf von der Schulenburg, JM, Greiner, W, Jost, F, et al. (2008) Hanover Consensus Group. German recommendations on health economic evaluation: third and updated version of the Hanover Consensus. Value Health 11, 539544.
10McCarron, DA & Heaney, RP (2004) Estimated healthcare savings associated with adequate dairy food intake. Am J Hypertens 17, 8897.
11Dall, TM, Fulgoni, VL III, Zhang, Y, et al. (2009) Potential health benefits and medical cost savings from calorie, sodium, and saturated fat reductions in the American diet. Am J Health Promot 23, 412422.
12Dall, TM, Fulgoni III, VL, Zhang, Y, et al. (2009) Predicted national productivity implications of calorie and sodium reductions in the American diet. Am J Health Promot 23, 23430.
13Cox, HL, Laupland, KB & Manns, BJ (2006) Economic evaluation in critical care medicine. J Crit Care 21, 117124.
14Heaney, RP (2008) Nutrients, endpoints, and the problem of proof. J Nutr 138, 15911595.
15Heaney, RP & Rafferty, K (2009) Preponderance of the evidence, an example from the issue of calcium intake and body composition. Nutr Rev 67, 3239.
16Koretz, RL (2005) Nutrition Society Symposium on end points in clinical nutrition trials. Death, morbidity and economics are the only end points for trials. Proc Nutr Soc 64, 277–-284.
17Wahlqvist, ML, Hsu-Hage, BH-H & Lukito, W (1999) Clinical trials in nutrition. Asia Pac J Clin Nutr 8, 231241.
18Genton, L, van Gemert, W, Pichard, C, et al. (2005) Physiological functions should be considered as true end points of nutritional intervention studies. Proc Nutr Soc 64, 285296.
19Commission Directive (1999) EC of 25 March 1999 on dietary foods for special medical purposes. http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri = CELEX:31999L0021:EN:NOT.
20Paré, P, Gray, J, Lam, S, et al. (2006) Health-related quality of life, work productivity, and health care resource utilization of subjects with irritable bowel syndrome: baseline results from LOGIC (Longitudinal Outcomes Study of Gastrointestinal Symptoms in Canada), a naturalistic study. Clin Ther 28, 17261735.
21Ravasco, P, Monteiro-Grillo, I, Vidal, PM, et al. (2004) Cancer, disease and nutrition are key determinants of patients' quality of life. Support Care Cancer 12, 246252.
22NICE (2006) Modelling the cost-effectiveness of physical activity interventions. National Institute for Health and Clinical Excellence. http://www.nice.org.uk/nicemedia/pdf/FourmethodsEconomicModellingReport.pdf.
23Bidlack, WR (1996) Interrelationships of food, nutrition, diet and health: The National Association of State Universities and Land Grant Colleges White Paper. J Am Coll Nutr 15, 422433.
24Cohen, JT, Neumann, PJ & Weinstein, MC (2008) Does preventive care save money? Health economics and the presidential candidates. N Engl J Med 358, 661663.
25Kahn, R, Robertson, RM, Smith, R, et al. (2008) The impact of prevention on reducing the burden of cardiovascular disease. Circulation 118, 576585.
26Kim, JJ & Goldie, SJ (2008) Health and economic implications of HPV vaccination in the United States. N Engl J Med 359, 821832.
27Gliklich, RE & Dreyer, NA (editors) (2007) Registries Evaluating Patient Outcomes: A User's Guide. Agency for Healthcare Research and Quality.
28AHRQ Conference on Health Care Data Collection and Reporting – Collecting and Reporting Data for Performance Measurement, Moving Toward Alignment (2006) Report of Proceedings. http://healthit.ahrq.gov/portal/server.pt/gateway/PTARGS_O_227079_O_O_18/AHRQ_DataReport_final.pdf.
29Jacobs, P, Bachynsky, J & Baladi, JF (1995) A comparative review of pharmacoeconomic guidelines. Pharmacoeconomics 8, 182189.
30Weinstein, MC & Fineberg, HV (1980) Clinical Decision Analysis, pp. 228265. Philadelphia, PA: WB Saunders Co.
31Suarez, FL, Savaiano, D, Arbisi, P, et al. (1997) Tolerance to the daily ingestion of two cups of milk by individuals claiming lactose intolerance. Am J Clin Nutr 65, 15021506.
32McBean, LD & Miller, GD (1998) Allaying fears and fallacies about lactose intolerance. J Am Diet Assoc 98, 671676.
33Savaiano, DA, Boushey, CJ & McCabey, GP (2006) Lactose intolerance symptoms assessed by meta-analysis: a grain of truth that leads to exaggeration. J Nutr 136, 11071113.
34Nicklas, TA, Qu, H, Hughes, SO, et al. (2009) Prevalence of self-reported lactose intolerance in a multiethnic sample of adults. Nutr Today 44, 222227.
35Drummond, M, Brixner, D, Gold, M, et al. (2009) (Consensus Development Group) Toward a consensus on the QALY. Value Health 12, S31S35.
36Rutten-van Mölken, M, Van Busschbach, J and Rutten, F (editors) (2000) From costs to effects: a manual for evaluation studies in health care [in Dutch]. Elsevier Gezondheidszorg.
37Peter, A, Taylor, R, Butler, J, et al. (2003) Returns on Investment in Public Health, an Epidemiological and Economic Analysis. Australian Government. Department of Health and Ageing.
38Claes, C, Reinert, RR & von der Schulenburg, JM (2009) Cost effectiveness analysis of heptavalent pneumococcal conjugate vaccine in Germany considering herd immunity effects. Eur J Health Econ 10, 2538.
39Gravelle, H & Smith, D (2000) Discounting for Health Effects in Cost Benefit and Cost Effectiveness Analysis, pp. 20. Centre for Health Economics Technical Paper Series 20.
40Viscusi, WK (1995) Discounting Health Effects for Medical Decisions. Valuing Health Care, pp. 125147. [Sloan, FA, editor]. Cambridge: Cambridge University Press.
41Sloan, FA (1995) Valuing Health Care. Costs, Benefits and Effectiveness of Pharmaceuticals and Other Medical Technologies. Cambridge: Cambridge University Press.
42Robinson, R (1993) Economic evaluation and health care. What does it mean? Br Med J 307, 670673.
43Adams, ME, McCall, NT, Gray, DT, et al. (1992) Economic analysis in randomised controlled trials. Med Care 30, 231243.
44Drummond, MF & Davies, L (1991) Economic analysis alongside clinical trials. Revisiting the methodological issues. Int J Technol Assess Health Care 7, 561573.
45Drummond, MF, Ludbrook, A, Lowson, K, et al. (1986) Studies in Economic Appraisal in Health Care, vol. 2.Oxford: Oxford University Press.
46Framingham Heart Study 1951–2010. http://www.framinghamheartstudy.org/biblio/index.html.
47Arriola, L, Martinez-Camblor, P, Larrañaga, N, et al. (2010) Alcohol intake and the risk of coronary heart disease in the Spanish EPIC cohort study. Heart 96, 124130.

Keywords

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed